The requested URL was not found on this server. That’s all we know.
Background
Patients with limited English proficiency frequently receive substandard health care. Asynchronous telepsychiatry (ATP) has been established as a clinically valid method for psychiatric assessments. The addition of automated speech recognition (ASR) and automated machine translation (AMT) technologies to asynchronous telepsychiatry may be a viable artificial intelligence (AI)–language interpretation option.
Objective
This project measures the frequency and accuracy of the translation of figurative language devices (FLDs) and patient word count per minute, in a subset of psychiatric interviews from a larger trial, as an approximation to patient speech complexity and quantity in clinical encounters that require interpretation.
Methods
A total of 6 patients were selected from the original trial, where they had undergone 2 assessments, once by an English-speaking psychiatrist through a Spanish-speaking human interpreter and once in Spanish by a trained mental health interviewer-researcher with AI interpretation. 3 (50%) of the 6 selected patients were interviewed via videoconferencing because of the COVID-19 pandemic. Interview transcripts were created by automated speech recognition with manual corrections for transcriptional accuracy and assessment for translational accuracy of FLDs.
Results
AI-interpreted interviews were found to have a significant increase in the use of FLDs and patient word count per minute. Both human and AI-interpreted FLDs were frequently translated inaccurately, however FLD translation may be more accurate on videoconferencing.
Conclusions
AI interpretation is currently not sufficiently accurate for use in clinical settings. However, this study suggests that alternatives to human interpretation are needed to circumvent modifications to patients’ speech. While AI interpretation technologies are being further developed, using videoconferencing for human interpreting may be more accurate than in-person interpreting.
Trial Registration
ClinicalTrials.gov NCT03538860; https://clinicaltrials.gov/ct2/show/NCT03538860
Keywords: telepsychiatry, automated machine translation, language barriers, psychiatry, assessment, automated translation, automated, translation, artificial intelligence, AI, speech recognition, limited English proficiency, LEP, asynchronous telepsychiatry, ATP, automated speech recognition, ASR, AMT, figurative language device, FLD, language concordant, language discordant, AI interpretation
AsyncHealth is the Mental Health Platform for Health Systems and Enterprise. Rapid, reliable mental health triage and clinical consultation with research-grade asynchronous telepsychiatry, built for businesses that serve clients
Visit us at AsyncHealth.com and follow us on LinkedIn.